Poison Pill Increasingly A Tough Call

Law360, New York (October 7, 2009, 1:17 PM EDT) -- Weighing whether to adopt or extend a poison pill as part of a takeover defense strategy has become an increasingly complicated process for public companies, and recent pushes for corporate governance reforms promise to make the decision even more complex, experts say.

It’s a decision that a number of public companies have to face this year: More than 200 companies have a decade-old poison pill set to expire, according to data released by FactSet SharkRepellent, a tracker of takeover defenses.

A typical poison pill used to...
To view the full article, register now.